LAMBERTI, GIUSEPPE
LAMBERTI, GIUSEPPE
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
Ricercatori a tempo determinato
[177Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspective
2021 Spada F.; Campana D.; Lamberti G.; Laudicella R.; Dellamano R.; Dellamano L.; Leeuwenkamp O.; Baldari S.
[68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time?
2022 Tabacchi E.; Fortunati E.; Argalia G.; Zanoni L.; Calabro D.; Telo S.; Campana D.; Lamberti G.; Ricci C.; Casadei R.; Fanti S.; Ambrosini V.
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale
2022 Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Follador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea
An overview on molecular characterization of thymic tumors: Old and new targets for clinical advances
2021 Tateo V.; Manuzzi L.; Parisi C.; De Giglio A.; Campana D.; Pantaleo M.A.; Lamberti G.
Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience
2020 Vitale G.; Lamberti G.; Comito F.; Di Nunno V.; Massari F.; Morelli M.C.; Ardizzoni A.; Gelsomino F.
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study
2022 Ricci A.D.; Pusceddu S.; Panzuto F.; Gelsomino F.; Massironi S.; De Angelis C.G.; Modica R.; Ricco G.; Torchio M.; Rinzivillo M.; Prinzi N.; Rizzi F.; Lamberti G.; Campana D.
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors
2022 Pusceddu, Sara; Prinzi, Natalie; Tafuto, Salvatore; Ibrahim, Toni; Filice, Angelina; Brizzi, Maria Pia; Panzuto, Francesco; Baldari, Sergio; Grana, Chiara M.; Campana, Davide; Davì, Maria Vittoria; Giuffrida, Dario; Zatelli, Maria Chiara; Partelli, Stefano; Razzore, Paola; Marconcini, Riccardo; Massironi, Sara; Gelsomino, Fabio; Faggiano, Antongiulio; Giannetta, Elisa; Bajetta, Emilio; Grimaldi, Franco; Cives, Mauro; Cirillo, Fernando; Perfetti, Vittorio; Corti, Francesca; Ricci, Claudio; Giacomelli, Luca; Porcu, Luca; Di Maio, Massimo; Seregni, Ettore; Maccauro, Marco; Lastoria, Secondo; Bongiovanni, Alberto; Versari, Annibale; Persano, Irene; Rinzivillo, Maria; Pignata, Salvatore Antonio; Rocca, Paola Anna; Lamberti, Giuseppe; Cingarlini, Sara; Puliafito, Ivana; Ambrosio, Maria Rosaria; Zanata, Isabella; Bracigliano, Alessandra; Severi, Stefano; Spada, Francesca; Andreasi, Valentina; Modica, Roberta; Scalorbi, Federica; Milione, Massimo; Sabella, Giovanna; Coppa, Jorgelina; Casadei, Riccardo; Di Bartolomeo, Maria; Falconi, Massimo; de Braud, Filippo
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial)
2020 Gelsomino F.; Lamberti G.; Tiseo M.; Rocco D.; Pasello G.; Cecere F.L.; Chella A.; Grilli G.; Mandruzzato M.; Tognetto M.; Garassino M.C.; Macerelli M.; Novello S.; Roila F.; Colantonio I.; Grossi F.; Fiorentino M.; Ardizzoni A.
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma
2020 Lamberti G.; Andrini E.; Sisi M.; Rizzo A.; Parisi C.; Di Federico A.; Gelsomino F.; Ardizzoni A.
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study
2020 Brighi N.; Panzuto F.; Modica R.; Gelsomino F.; Albertelli M.; Pusceddu S.; Massironi S.; Lamberti G.; Rinzivillo M.; Faggiano A.; Spallanzani A.; Ferone D.; Prinzi N.; Rossi R.E.; Annibale B.; Colao A.M.; Campana D.
Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparities
2022 De Giglio A.; Orlando V.; Andrini E.; Ricciuti B.; Lamberti G.; Chiari R.
Complete Recalcification Following Arterial Embolization of Massive Osteolytic Bone Metastasis From NSCLC
2019 Francesco Gelsomino,Giancarlo Facchini, Maria Aurelia Barbera, Giuseppe Lamberti, Stefano Brocchi, Giuseppe Rossi, Andrea Ardizzoni
Concordance between RTOG and EORTC prognostic criteria in low-grade gliomas
2019 Franceschi E.; Mura A.; Lamberti G.; De Biase D.; Tosoni A.; Di Battista M.; Argento C.; Visani M.; Paccapelo A.; Bartolini S.; Brandes A.A.
Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study From the French Group of Endocrine Tumors (GTE)
2019 Lamberti, Giuseppe; Brighi, Nicole; Campana, Davide
Cutaneous Scapular Lesion in an Elderly Woman
2019 Brighi N.; Lamberti G.; Campana D.
Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors
2017 Lamberti, G; Ceccarelli, C; Brighi, N; Maggio, I; Santini, D; Mosconi, C; Ricci, C; Biasco, G; Campana, D.
Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer
2020 Parisi C.; Lamberti G.; Zompatori M.; Gelsomino F.; Salvagni S.; Sperandi F.; Ardizzoni A.
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management
2020 Panzuto F.; Massironi S.; Partelli S.; Campana D.; Rinzivillo M.; Invernizzi P.; Andreasi V.; Lamberti G.; Falconi M.
Immunobiology of thymic epithelial tumors: Implications for immunotherapy with immune checkpoint inhibitors
2020 Tateo V.; Manuzzi L.; De Giglio A.; Parisi C.; Lamberti G.; Campana D.; Pantaleo M.A.
Landscape and future perspectives of immunotherapy in neuroendocrine neoplasia
2020 Maggio I.; Manuzzi L.; Lamberti G.; Ricci A.D.; Tober N.; Campana D.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| [177Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspective | Spada F.; Campana D.; Lamberti G.; Laudicella R.; Dellamano R.; Dellamano L.; Leeuwenkamp O.; Bal...dari S. | 2021-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| [68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time? | Tabacchi E.; Fortunati E.; Argalia G.; Zanoni L.; Calabro D.; Telo S.; Campana D.; Lamberti G.; R...icci C.; Casadei R.; Fanti S.; Ambrosini V. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-03541.pdf |
| A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale | Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Fo...llador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea | 2022-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| An overview on molecular characterization of thymic tumors: Old and new targets for clinical advances | Tateo V.; Manuzzi L.; Parisi C.; De Giglio A.; Campana D.; Pantaleo M.A.; Lamberti G. | 2021-01-01 | PHARMACEUTICALS | - | 1.01 Articolo in rivista | pharmaceuticals-14-00316.pdf |
| Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience | Vitale G.; Lamberti G.; Comito F.; Di Nunno V.; Massari F.; Morelli M.C.; Ardizzoni A.; Gelsomino F. | 2020-01-01 | EXPERT OPINION ON BIOLOGICAL THERAPY | - | 1.01 Articolo in rivista | - |
| Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study | Ricci A.D.; Pusceddu S.; Panzuto F.; Gelsomino F.; Massironi S.; De Angelis C.G.; Modica R.; Ricc...o G.; Torchio M.; Rinzivillo M.; Prinzi N.; Rizzi F.; Lamberti G.; Campana D. | 2022-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-11-00713-v2.pdf |
| Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors | Pusceddu, Sara; Prinzi, Natalie; Tafuto, Salvatore; Ibrahim, Toni; Filice, Angelina; Brizzi, Mari...a Pia; Panzuto, Francesco; Baldari, Sergio; Grana, Chiara M.; Campana, Davide; Davì, Maria Vittoria; Giuffrida, Dario; Zatelli, Maria Chiara; Partelli, Stefano; Razzore, Paola; Marconcini, Riccardo; Massironi, Sara; Gelsomino, Fabio; Faggiano, Antongiulio; Giannetta, Elisa; Bajetta, Emilio; Grimaldi, Franco; Cives, Mauro; Cirillo, Fernando; Perfetti, Vittorio; Corti, Francesca; Ricci, Claudio; Giacomelli, Luca; Porcu, Luca; Di Maio, Massimo; Seregni, Ettore; Maccauro, Marco; Lastoria, Secondo; Bongiovanni, Alberto; Versari, Annibale; Persano, Irene; Rinzivillo, Maria; Pignata, Salvatore Antonio; Rocca, Paola Anna; Lamberti, Giuseppe; Cingarlini, Sara; Puliafito, Ivana; Ambrosio, Maria Rosaria; Zanata, Isabella; Bracigliano, Alessandra; Severi, Stefano; Spada, Francesca; Andreasi, Valentina; Modica, Roberta; Scalorbi, Federica; Milione, Massimo; Sabella, Giovanna; Coppa, Jorgelina; Casadei, Riccardo; Di Bartolomeo, Maria; Falconi, Massimo; de Braud, Filippo | 2022-01-01 | JAMA NETWORK OPEN | - | 1.01 Articolo in rivista | pusceddu_2022_oi_220024_1645038635.48021.pdf |
| Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial) | Gelsomino F.; Lamberti G.; Tiseo M.; Rocco D.; Pasello G.; Cecere F.L.; Chella A.; Grilli G.; Man...druzzato M.; Tognetto M.; Garassino M.C.; Macerelli M.; Novello S.; Roila F.; Colantonio I.; Grossi F.; Fiorentino M.; Ardizzoni A. | 2020-01-01 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | - | 1.01 Articolo in rivista | Gelsomino_CHANCE_TAMO'20.pdf |
| Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma | Lamberti G.; Andrini E.; Sisi M.; Rizzo A.; Parisi C.; Di Federico A.; Gelsomino F.; Ardizzoni A. | 2020-01-01 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study | Brighi N.; Panzuto F.; Modica R.; Gelsomino F.; Albertelli M.; Pusceddu S.; Massironi S.; Lambert...i G.; Rinzivillo M.; Faggiano A.; Spallanzani A.; Ferone D.; Prinzi N.; Rossi R.E.; Annibale B.; Colao A.M.; Campana D. | 2020-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |
| Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparities | De Giglio A.; Orlando V.; Andrini E.; Ricciuti B.; Lamberti G.; Chiari R. | 2022-01-01 | TUMORI | - | 1.01 Articolo in rivista | - |
| Complete Recalcification Following Arterial Embolization of Massive Osteolytic Bone Metastasis From NSCLC |
Francesco Gelsomino,Giancarlo Facchini, Maria Aurelia Barbera, Giuseppe Lamberti, Stefano Bro...cchi, Giuseppe Rossi, Andrea Ardizzoni |
2019-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Concordance between RTOG and EORTC prognostic criteria in low-grade gliomas | Franceschi E.; Mura A.; Lamberti G.; De Biase D.; Tosoni A.; Di Battista M.; Argento C.; Visani M....; Paccapelo A.; Bartolini S.; Brandes A.A. | 2019-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study From the French Group of Endocrine Tumors (GTE) | Lamberti, Giuseppe; Brighi, Nicole; Campana, Davide | 2019-01-01 | ANNALS OF SURGERY | - | 1.04 Replica / breve intervento (e simili) | - |
| Cutaneous Scapular Lesion in an Elderly Woman | Brighi N.; Lamberti G.; Campana D. | 2019-01-01 | JAMA ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors | Lamberti, G; Ceccarelli, C; Brighi, N; Maggio, I; Santini, D; Mosconi, C; Ricci, C; Biasco, G; Ca...mpana, D. | 2017-01-01 | GASTROENTEROLOGY RESEARCH AND PRACTICE | - | 1.01 Articolo in rivista | 787251.pdf |
| Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer | Parisi C.; Lamberti G.; Zompatori M.; Gelsomino F.; Salvagni S.; Sperandi F.; Ardizzoni A. | 2020-01-01 | JOURNAL FOR IMMUNOTHERAPY OF CANCER | - | 1.01 Articolo in rivista | Parisi_Cystic airspaces_JIC'20.pdf |
| Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management | Panzuto F.; Massironi S.; Partelli S.; Campana D.; Rinzivillo M.; Invernizzi P.; Andreasi V.; Lam...berti G.; Falconi M. | 2020-01-01 | SURGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Immunobiology of thymic epithelial tumors: Implications for immunotherapy with immune checkpoint inhibitors | Tateo V.; Manuzzi L.; De Giglio A.; Parisi C.; Lamberti G.; Campana D.; Pantaleo M.A. | 2020-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | - |
| Landscape and future perspectives of immunotherapy in neuroendocrine neoplasia | Maggio I.; Manuzzi L.; Lamberti G.; Ricci A.D.; Tober N.; Campana D. | 2020-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-12-00832-v2.pdf |